3.4.24.77	1,10-phenanthroline	-	62	
3.4.24.77	1,10-phenanthroline	1 mM, complete inhibition	62	
3.4.24.77	antipain dihydrochloride	0.074 mM, 94.9% residual proteolytic activity	59025	
3.4.24.77	Ca2+	more than 2 mM	15	
3.4.24.77	chymostatin	0.1 mM, 91.7% residual proteolytic activity	511	
3.4.24.77	Cu2+	10 mM, 46% inhibition	19	
3.4.24.77	diisopropyl fluorophosphate	-	244	
3.4.24.77	DTT	-	177	
3.4.24.77	EDTA	-	21	
3.4.24.77	EDTA	1.3 mM, no residual proteolytic activity	21	
3.4.24.77	EDTA	1 mM, complete inhibition	21	
3.4.24.77	EDTA	10 mM, 74% inhibition	21	
3.4.24.77	FeSO4	2 mM, activity decreases to less than 20% of the maximum	655	
3.4.24.77	HgCl2	-	110	
3.4.24.77	iodoacetamide	-	67	
3.4.24.77	additional information	no inhibitory effect of phenyl-methyl-sulfonyl-fluoride and p-chlormercuribenzoate	2	
3.4.24.77	N-bromosuccinimide	1 mM, 97% inhibition	208	
3.4.24.77	N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]leucine	0.13 mM, 96.1% residual proteolytic activity	132630	
3.4.24.77	NiSO4	2 mM, activity decreases to less than 20% of the maximum	2860	
3.4.24.77	pefabloc	1 mM, 82.3% residual proteolytic activity	2236	
3.4.24.77	Phenanthroline	-	4856	
3.4.24.77	phenyl-methyl-sulfonyl-fluoride	-	132631	
3.4.24.77	phosphoramidon	0.6 mM, no residual proteolytic activity	645	
3.4.24.77	thiorphan	0.001 mM and 0.0001 mM, 35% and 47% inhibition, respectively	1128	
3.4.24.77	Zn2+	0.01 mM	14	
3.4.24.77	ZnSO4	2 mM, activity decreases to less than 20% of the maximum	485